UPMC Enterprises
UPMC Enterprises is the venture and innovation arm of UPMC, investing across stages in healthcare AI, digital health, and therapeutics while commercializing the Ahavi real-world clinical data platform and running 200–250 industry-sponsored clinical trials annually.
- Company typePrivate
- Founded2015
- HeadquartersPittsburgh, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What UPMC Enterprises does
UPMC Enterprises is the innovation, commercialization, and venture capital arm of UPMC, a $28 billion private healthcare provider and insurer headquartered in Pittsburgh. The firm operates two strategic focus areas — Translational Sciences (diagnostics and therapeutics) and Digital Solutions (digital health technologies) — and invests across stages from seed to growth through an evergreen capital model backed by the parent system. It serves healthcare startups needing capital, clinical validation pathways, and distribution access; pharmaceutical and biotech sponsors running industry-sponsored trials; and AI developers seeking high-quality real-world clinical data.
The firm's core technology asset is Ahavi™, a real-world data platform providing secure access to de-identified clinical records from 5 million patients across 24 UPMC hospitals, including 156 million structured patient encounters and over 154 million ambulatory documents with structured-to-unstructured linkage rates of 80–99%. Datasets are normalized and delivered within 2–4 weeks. Supporting initiatives include the Center for Connected Medicine (a thought-leadership and events platform), the Pittsburgh Health Data Alliance with Carnegie Mellon and University of Pittsburgh, and the OnCore-based Sponsored Clinical Trials and Partnerships program activating 200–250 industry-sponsored trials annually across 25+ departments.
UPMC Enterprises generates revenue through venture capital returns on a portfolio spanning BrainCheck, Carta Healthcare, RAAPID, Penguin AI, Koda Health, Precede Biosciences, and Interra Health (formed from the DoseSpot–Arrive Health merger). Clinical trial services for pharmaceutical sponsors provide a second revenue stream, and Ahavi represents an emerging external commercialization surface. Investment and trial economics are not publicly disclosed.
UPMC Enterprises firmographics
Firmographics- Name
- UPMC Enterprises
- Legal name
- UPMC Enterprises
- Website
- https://enterprises.upmc.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- UPMC Enterprises is the venture and innovation arm of UPMC, investing across stages in healthcare AI, digital health, and therapeutics while commercializing the Ahavi real-world clinical data platform and running 200–250 industry-sponsored clinical trials annually.
- Ownership category
- akta.pro rank
UPMC Enterprises industry classification
Industry- Product category
- Healthcare Venture Capital and Innovation Services
- NAICS
- Management of Companies and Enterprises (55111)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)
- akta.pro secondary industry
- Corporate Deep Tech / R&D Commercialization CVC (FSANAHAL)
Keywords
Where UPMC Enterprises is headquartered
LocationHeadquarters
- HQ city
- Pittsburgh
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
UPMC Enterprises business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Venture Capital Returns: UPMC Enterprises generates returns through equity investments in healthcare innovation companies. As an evergreen investment platform, they deploy capital across therapeutics, digital health, and translational sciences, seeking to build and scale high-impact healthcare companies.
- Clinical Trials Services: UPMC activates approximately 200-250 industry-initiated sponsored trials annually, supporting complex multi-site research across more than 25 departments and UPMC Hillman Cancer Center.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
UPMC Enterprises product offering
Product offeringCore offering
UPMC Enterprises operates as the innovation, commercialization, and venture capital arm of UPMC, investing in early- to growth-stage healthcare companies across Therapeutics, Digital Health, and Translational Sciences. It also operates the Ahavi real-world healthcare data platform, which provides secure access to de-identified clinical data from UPMC's patient population, and manages the UPMC Sponsored Clinical Trials and Partnerships program for industry sponsors.
Product overview
UPMC Enterprises operates as the innovation, commercialization, and venture capital arm of UPMC ($28 billion health system) with two strategic focus areas: Translational Sciences (diagnostics and therapeutics) and Digital Solutions. The core technology offering includes Ahavi™, a real-world data platform that provides secure access to de-identified clinical data from over 5 million patients across 24 hospitals, enabling AI model validation, clinical trial design, and healthcare R&D. Supporting initiatives include the Center for Connected Medicine (CCM) for industry collaboration and events, MyUPMC patient app, and the Pittsburgh Health Data Alliance research partnership. The investment portfolio spans digital health, biotech, and life sciences companies including BrainCheck (cognitive assessment), Carta Healthcare (clinical data abstraction), RAAPID (risk adjustment AI), and Penguin Ai (administrative automation).
Differentiator
Problem solved
Functional benefit
Brands
- Ahavi: Real-world health care data platform providing secure access to de-identified clinical data from UPMC's patient population to accelerate discoveries and improve patient care.
- Center for Connected Medicine (CCM)
- Pittsburgh Health Data Alliance (PHDA)
Products and services
- Ahavi Real-World Data Platform Real-world healthcare data platform providing secure access to de-identified clinical data from UPMC's patient population (5M+ patients across 24 hospitals), enabling AI model validation, clinical trial design, and research acceleration by integrating structured and unstructured data from EHRs, radiology, and pathology reports.
- UPMC Sponsored Clinical Trials and Partnerships Centralized clinical trial management program providing industry sponsors streamlined access to UPMC's clinical research infrastructure, featuring OnCore CTMS and Ahavi real-world data integration. Activates approximately 200-250 industry-sponsored trials annually across more than 25 departments.
- Healthcare Investment Portfolio Evergreen investment platform deploying capital from early- to growth-stage in healthcare innovation companies, providing portfolio companies with capital, connections, and resources including access to UPMC's clinical infrastructure for validation and pilots.
Quantifiable outcome
- Ahavi delivers normalized and de-identified datasets within 2-4 weeks, significantly faster than traditional methods
- +2 more outcomes
Companies that use UPMC Enterprises
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
UPMC Enterprises technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature4 records
UPMC Enterprises partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Penguin AIcoreUPMC Enterprises entered a strategic partnership with Penguin AI to advance healthcare-specific AI models using UPMC's Ahavi secure data platform. Through the collaboration, Penguin AI leverages Ahavi to develop healthcare AI systems including Patient 360 and Enhanced Prior Authorization, designed to improve clinical decision-making and reduce administrative burdens.
- Carnegie Mellon UniversitycoreUPMC Enterprises participated as judges in the Forge to Field AI Pitch Competition hosted by Carnegie Mellon University's Swartz Center for Entrepreneurship and AI Strike Team, distributing over $1.75 million in potential investments during NFL Draft Week.
- NokiacoreNokia supports the Center for Connected Medicine at UPMC, collaborating with UPMC Enterprises to bring together leaders and innovators striving to advance healthcare through programming that informs, connects, and inspires.
- KLAS ResearchcoreUPMC Enterprises and KLAS Research collaborate on healthcare research including reports on precision medicine, clinical trials, AI in healthcare, and ambulatory care strategies at health systems.
- Realyze Intelligence (Acquired by Carta Healthcare)minorCarta Healthcare acquired Realyze Intelligence from UPMC Enterprises in November 2024 to expand into clinical trials. This built on prior collaboration in clinical data management.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
UPMC Enterprises competitors and assessment
Company assessmentDirect peers
- OSF Ventures: The venture arm of OSF HealthCare, a large integrated Catholic health system. Direct peer because it invests in digital health and care delivery startups using OSF's clinical network, very similar in structure and scale to UPMC Enterprises.
- Optum Ventures: The corporate venture arm of UnitedHealth Group's Optum, investing across healthcare AI, digital health, and care delivery. Direct peer because it operates the same model: a CVC funded by a major integrated payer-provider, leveraging clinical and data assets to back healthcare innovation companies.
- Mayo Clinic Ventures: The technology transfer and venture arm of Mayo Clinic. Direct peer because it commercializes clinical innovations and invests in healthcare startups using Mayo's clinical research infrastructure—essentially the same role UPMC Enterprises plays within UPMC.
- Kaiser Permanente Ventures: The strategic venture arm of Kaiser Permanente, one of the largest integrated US health systems. Direct peer because it invests across healthcare technology and services using Kaiser's clinical infrastructure and patient population, mirroring UPMC Enterprises' model.
- Cleveland Clinic Innovations: The commercialization and venture arm of Cleveland Clinic. Direct peer because it spins out and invests in healthcare companies leveraging Cleveland Clinic's clinical expertise and IP, paralleling UPMC Enterprises' Translational Sciences function.
- Memorial Hermann Innovation: The innovation and venture arm of Memorial Hermann Health System. Comparable to UPMC Enterprises as a regional health system-backed CVC deploying capital and clinical infrastructure into digital health and care delivery startups.
- Geisinger Ventures: The investment and commercialization arm of Geisinger Health. Comparable to UPMC Enterprises as a Pennsylvania-based integrated health system CVC focused on healthcare technology innovation and translational research.
Broad incumbents
- Andreessen Horowitz (Bio/Health): A major independent venture firm with dedicated bio/health funds. Comparable in that it invests across the same healthcare AI and biotech categories that UPMC Enterprises targets, but at much greater scale and from a pure-financial-return perspective.
- General Catalyst (Health): A leading independent VC with a dedicated health system transformation practice partnering with major US health systems. Adjacent to UPMC Enterprises because it competes for healthcare AI and digital health deals, though it operates without corporate-parent backing.
- Bessemer Venture Partners (Healthcare): Major independent venture firm with a substantial healthcare practice. Comparable to UPMC Enterprises in that it actively invests across healthcare AI, biotech, and digital health—but operates as an independent VC rather than a corporate subsidiary.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
UPMC Enterprises social profiles
Digital presenceUPMC Enterprises financial estimates
Financial estimateRevenue estimate
Valuation estimate
UPMC Enterprises leadership team
Management profileNumber of profiles
Profiles20 records
UPMC Enterprises funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UPMC Enterprises M&A and investment
M&A and investmentM&A
Investments49 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UPMC Enterprises
What does UPMC Enterprises do?
UPMC Enterprises operates as the innovation, commercialization, and venture capital arm of UPMC, investing in early- to growth-stage healthcare companies across Therapeutics, Digital Health, and Translational Sciences. It also operates the Ahavi real-world healthcare data platform, which provides secure access to de-identified clinical data from UPMC's patient population, and manages the UPMC Sponsored Clinical Trials and Partnerships program for industry sponsors.
Is UPMC Enterprises a public or private company?
UPMC Enterprises is a private company. It is classified as corporate owned and is currently operating.
When was UPMC Enterprises founded?
UPMC Enterprises was founded in 2015. It employs 51 to 100 people.
Where is UPMC Enterprises based?
UPMC Enterprises is headquartered in Pittsburgh, United States, in the North America region.
How does UPMC Enterprises make money?
Two revenue lines are on record. Venture Capital Returns are the primary driver. The others are clinical Trials Services.
Who are UPMC Enterprises's main competitors?
Direct peers on record are OSF Ventures, Optum Ventures, Mayo Clinic Ventures, Kaiser Permanente Ventures, Cleveland Clinic Innovations, Memorial Hermann Innovation and Geisinger Ventures. Broad incumbents are Andreessen Horowitz (Bio/Health), General Catalyst (Health) and Bessemer Venture Partners (Healthcare).
Does UPMC Enterprises have an API?
No public API is recorded for UPMC Enterprises.
What industry is UPMC Enterprises in?
UPMC Enterprises's product category is Healthcare Venture Capital and Innovation Services. Its primary akta.pro industry code is FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms, with a secondary code of FSANAHAL, Corporate Deep Tech / R&D Commercialization CVC. Its NAICS code is 55111 and its SIC code is 6211.